Patent · US Active

Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors

US9663535B2 · kind B2 · utility

3Cited by

0References

54Claims

0Family size

Assignee

Atrin Pharmaceuticals LLC · US

Inventors

Henry J. Breslin · Lansdale, US
Oren Gilad · Ambler, US

Key dates

Filing date	Oct 13, 2015
Grant date	May 30, 2017
Priority date	—
Expiry date	Oct 13, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D515/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Macrocyclic compounds having the structure of Formula (A), or pharmaceutically acceptable salts thereof, are provided,wherein R1, R2, Z1, Z2, v, T, L, R3, R4 and R5 are defined herein. Also provided are pharmaceutical compositions comprising the macrocyclic compound and methods for treating cancer in a patient comprising administering to the patient the macrocyclic compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.